Business Context and Reporting Period
Company: Oric Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2025
Reporting Period: Event date January 13, 2025
Context: The filing discloses the Company's intention to present an updated corporate presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025. The presentation is included as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a corporate presentation rather than a financial results report.
Material Changes
No material financial changes or operational updates are detailed within the text of this 8-K filing. The document solely references the upcoming presentation at the J.P. Morgan Healthcare Conference.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to present an updated corporate presentation. The content of this presentation is furnished as an exhibit and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it subject to the liabilities of that section.
Risks and Contingencies: The filing includes standard disclaimers regarding the non-filing status of the presentation materials. No specific new risks or contingencies are disclosed in the text of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for specific clinical updates, financial guidance, or strategic outlooks not detailed in the 8-K text.
- Verify the date and time of the presentation at the 43rd Annual J.P. Morgan Healthcare Conference.
- Confirm that the presentation materials are not considered "filed" documents for liability purposes under Section 18 of the Exchange Act.